InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:	NEUREN PHARMACEUTICALS LIMITED (NEU)
ISIN:	NZNEUE0001S8
Date of Listing:	03 February 2005

Stock Exchange Status: (updated daily)

This entity is currently listed and quoted on the Australian Securities Exchange.

Legal Status: (updated monthly)

ACN: 111 496 130ABN: 72 111 496 130
Registration Date: 22 October 2004

This is a current registered entity, not in any form of external administration to our knowledge.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

NEUREN PHARMACEUTICALS LIMITED(NEU)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of NEU:

(5 out of 5)

COMPANY WEBSITE:

NEU website

NEU email

NEU investorRelations

NEU announcements

NEU annualreports

NEU directors

REGISTRY:

Liberty Place Level 41 161 Castlereagh St Sydney NSW 2000 Locked Bag A14 Sydney South NSW 1235

Tel : 1300 554 474
Fax : (02) 9287 0303 or (02) 9287 0309 (for voting)
RegistryWebsite RegistryEmail

Company details

ISIN: NZNEUE0001S8

Address: P.O Box 9923, New Market, AUCKLAND, NEW ZEALAND, 1001
Tel: +64 9 3700 200 Fax: +64 9 361 7981

Date first listed: 03/02/2005
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biopharmaceutical company with a focus on neuroprotection and metabolism.

News & Events

Expand this box to read and print

we understand that on or about this date the company consolidated its shares 1 for 20	29/11/2017
shares reinstated to quotation	18/11/2009
the securities of Neuren Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to capital raising initiatives	16/11/2009
the suspension of trading in the securities of Neuren Pharmaceuticals Limited (the "Company") will be lifted following the completion of its capital raising	06/08/2008
company requests an extension to the voluntary suspension of the Company's securities from official quotation pending an announcement in relation to a proposed capital raising by Neuren - Neuren proposes that the voluntary suspension be lifted at the earlier of the announcement or the commencement of trading on 6 August 2008	04/08/2008
shares suspended from quotation pending an announcement about a capital raising	31/07/2008
shares reinstated to quotation following receipt of an announcement providing details of the Company's capital raising	02/12/2005
shares suspended from quotation pending an announcement about a capital raising	01/12/2005

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
16/04/2025	Joe Basile	14,500	$10.563	$153,159.00
16/08/2024	Joe Basile	6,406	$15.730	$100,766.00
11/06/2024	Joe Basile	5,000	$19.490	$97,450.00
13/09/2023	Joe Basile	5,000	$11.990	$59,950.00
14/06/2023	Trevor Scott	-1,175,000	$13.000	$15,275,000.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Patrick Davies	Non Exec Chairman	04/07/2018
Jon Pilcher	Managing Director, CEO	19/08/2013
Lauren Frazer	CFO, Company Secretary	01/08/2020
Dianne Angus	Independent Director	03/07/2018
Joe Basile	Independent Director	02/03/2023
Trevor Scott	Non Exec Director	05/03/2002
Jenny Harry	Non Exec Director	04/07/2018

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.